Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Murrell

Showing results (341-350 of 490) with videos related to

Pageof 49
Sort By:
The Journal of Investigative Dermatology|December 11, 2012
Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisitaZlatko Kopecki, Nadira Ruzehaji, Christopher Turner, et al.
The Australasian Journal of Dermatology|February 8, 2012
Ectodermal dysplasia-skin fragility syndrome due to a new homozygous internal deletion mutation in the PKP1 geneAaron E Boyce, John A McGrath, Tanasit Techanukul, et al.
Acta Dermato-Venereologica|December 17, 2013
Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch populationWing Yan Yuen, John W Frew, Kelly Veerman, et al.
The British Journal of Dermatology|October 16, 2007
A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroidsD F Murrell, S Calvieri, J P Ortonne, et al.
Journal of Drugs in Dermatology : JDD|May 9, 2022
Critical Review of the Sentinel Lymph Node Surgery in Malignant MelanomaDipali Rathod, George Kroumpouzos, Aimilios Lallas, et al.
Cornea|February 5, 2015
Prospective study of ocular manifestations of pemphigus and bullous pemphigoid identifies a high prevalence of dry eye syndromeJeremy C K Tan, Lien T Tat, Kristy B Francis, et al.
The Cochrane Database of Systematic Reviews|November 28, 2018
Probiotics for treating eczemaAreti Makrgeorgou, Jo Leonardi-Bee, Fiona J Bath-Hextall, et al.
The Australasian Journal of Dermatology|May 27, 2025
Using Biologics to Reduce Long-Term Corticosteroid Use in Pyoderma Gangrenosum: Real-World Evidence From Two CentresR Cascio Ingurgio, A Alfano, L Gargiulo, et al.
Acta Dermato-Venereologica|June 30, 2017
Quality of Life in Greek Patients with Autoimmune Bullous Diseases Assessed with ABQOL and TABQOL IndexesAikaterini Patsatsi, Miltiadis Kokolios, Aikaterini Kyriakou, et al.
JAAD International|January 21, 2022
Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort studyYicong Liang, Faith A P Zeng, Tabrez Sheriff, et al.
Pageof 49

Showing results (341-350 of 490) with videos related to

Sort By:
Pageof 49
The Journal of Investigative Dermatology|December 11, 2012
Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisitaZlatko Kopecki, Nadira Ruzehaji, Christopher Turner, et al.
The Australasian Journal of Dermatology|February 8, 2012
Ectodermal dysplasia-skin fragility syndrome due to a new homozygous internal deletion mutation in the PKP1 geneAaron E Boyce, John A McGrath, Tanasit Techanukul, et al.
Acta Dermato-Venereologica|December 17, 2013
Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch populationWing Yan Yuen, John W Frew, Kelly Veerman, et al.
The British Journal of Dermatology|October 16, 2007
A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroidsD F Murrell, S Calvieri, J P Ortonne, et al.
Journal of Drugs in Dermatology : JDD|May 9, 2022
Critical Review of the Sentinel Lymph Node Surgery in Malignant MelanomaDipali Rathod, George Kroumpouzos, Aimilios Lallas, et al.
Cornea|February 5, 2015
Prospective study of ocular manifestations of pemphigus and bullous pemphigoid identifies a high prevalence of dry eye syndromeJeremy C K Tan, Lien T Tat, Kristy B Francis, et al.
The Cochrane Database of Systematic Reviews|November 28, 2018
Probiotics for treating eczemaAreti Makrgeorgou, Jo Leonardi-Bee, Fiona J Bath-Hextall, et al.
The Australasian Journal of Dermatology|May 27, 2025
Using Biologics to Reduce Long-Term Corticosteroid Use in Pyoderma Gangrenosum: Real-World Evidence From Two CentresR Cascio Ingurgio, A Alfano, L Gargiulo, et al.
Acta Dermato-Venereologica|June 30, 2017
Quality of Life in Greek Patients with Autoimmune Bullous Diseases Assessed with ABQOL and TABQOL IndexesAikaterini Patsatsi, Miltiadis Kokolios, Aikaterini Kyriakou, et al.
JAAD International|January 21, 2022
Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort studyYicong Liang, Faith A P Zeng, Tabrez Sheriff, et al.
Pageof 49